https://www.selleckchem.com/pr....oducts/Temsirolimus.
To characterize symptom-specific distress and impact on quality of life (QOL) among women with urge, passive, and combined urge/passive fecal incontinence (FI) phenotypes. A secondary aim was to characterize FI symptom-specific distress and impact on women with a novel fourth phenotype, stress FI. Women with at least monthly FI from 2003 to 2017 were included. Participants completed the Modified Manchester Health Questionnaire (MMHQ)including MHQand Fecal Incontinence Severity Index (FISI). Anorectal manometry (ARM) and endoanal ul
Like
Comment
Share
